DK0612246T3 - Farmaceutiske sammensætninger af galliumkomplekser med 3-hydroxy-4-pyroner - Google Patents

Farmaceutiske sammensætninger af galliumkomplekser med 3-hydroxy-4-pyroner

Info

Publication number
DK0612246T3
DK0612246T3 DK92905286T DK92905286T DK0612246T3 DK 0612246 T3 DK0612246 T3 DK 0612246T3 DK 92905286 T DK92905286 T DK 92905286T DK 92905286 T DK92905286 T DK 92905286T DK 0612246 T3 DK0612246 T3 DK 0612246T3
Authority
DK
Denmark
Prior art keywords
gallium
pharmaceutical compositions
pyrones
hydroxy
certain
Prior art date
Application number
DK92905286T
Other languages
Danish (da)
English (en)
Inventor
Lawrence Richard Bernstein
Original Assignee
Lawrence Richard Bernstein
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lawrence Richard Bernstein filed Critical Lawrence Richard Bernstein
Application granted granted Critical
Publication of DK0612246T3 publication Critical patent/DK0612246T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/34—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D309/36—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
    • C07D309/40—Oxygen atoms attached in positions 3 and 4, e.g. maltol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Nutrition Science (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK92905286T 1991-11-12 1991-11-12 Farmaceutiske sammensætninger af galliumkomplekser med 3-hydroxy-4-pyroner DK0612246T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA002122908A CA2122908C (en) 1991-11-12 1991-11-12 Pharmaceutical compositions of gallium complexes of 3-hydroxy-4-pyrones
PCT/US1991/008239 WO1993009776A1 (en) 1991-11-12 1991-11-12 Pharmaceutical compositions of gallium complexes of 3-hydroxy-4-pyrones

Publications (1)

Publication Number Publication Date
DK0612246T3 true DK0612246T3 (da) 2000-12-27

Family

ID=25677246

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92905286T DK0612246T3 (da) 1991-11-12 1991-11-12 Farmaceutiske sammensætninger af galliumkomplekser med 3-hydroxy-4-pyroner

Country Status (10)

Country Link
EP (1) EP0612246B1 (de)
JP (1) JP3348849B2 (de)
KR (1) KR100217001B1 (de)
AT (1) ATE195868T1 (de)
CA (1) CA2122908C (de)
DE (1) DE69132392T2 (de)
DK (1) DK0612246T3 (de)
ES (1) ES2151486T3 (de)
GR (1) GR3034862T3 (de)
WO (1) WO1993009776A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5747482A (en) * 1996-07-30 1998-05-05 Bernstein; Lawrence R. Methods and compositions to inhibit keratinocyte proliferation
CA2386325C (en) * 1999-10-04 2010-08-03 Lawrence R. Bernstein Gallium complexes of 3-hydroxy-4-pyrones to treat infection by intracellular prokaryotes, dna viruses and retroviruses
DE10113185A1 (de) * 2001-03-19 2002-10-24 Faustus Forschungs Cie Zusammensetzung, enthaltend einen Gallium(III)-Komplex und einen therapeutisch wirksamen Platin-Komplex
CA2550119A1 (en) * 2003-12-17 2005-06-30 Titan Pharmaceuticals, Inc. Use of gallium to treat inflammatory arthritis
EP2413698A4 (de) * 2009-03-30 2013-07-10 Niiki Pharma Inc Verfahren zur behandlung von osteoporose

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8329043D0 (en) * 1983-10-31 1983-11-30 Hider R C Pharmaceutical compositions
GB9006522D0 (en) * 1990-03-23 1990-05-23 Hider Robert C Metal complexes
WO1991017751A1 (en) * 1990-05-24 1991-11-28 Fujisawa, Inc. Orally administrable gallium compositions and methods of treatment therewith

Also Published As

Publication number Publication date
KR100217001B1 (ko) 1999-09-01
EP0612246B1 (de) 2000-08-30
WO1993009776A1 (en) 1993-05-27
ES2151486T3 (es) 2001-01-01
GR3034862T3 (en) 2001-02-28
CA2122908A1 (en) 1993-05-27
EP0612246A1 (de) 1994-08-31
DE69132392D1 (de) 2000-10-05
CA2122908C (en) 2004-08-17
JP3348849B2 (ja) 2002-11-20
ATE195868T1 (de) 2000-09-15
DE69132392T2 (de) 2001-06-07
JPH07504153A (ja) 1995-05-11
EP0612246A4 (de) 1995-04-19

Similar Documents

Publication Publication Date Title
KR940703676A (ko) 알렌드로네이트를 사용한 치근막 질환의 치료방법(Treatment of periodontal disease with alendronate)
AR020662A1 (es) Compuestos dihidrotiazoles policiclicos, procedimientos para su preparacion, medicamento, procedimiento para la preparacion de dicho medicamento y lautilizacion de dichos compuestos para la preparacion de un medicamento.
BR0011867A (pt) Preparação farmacêutica de levodopa/carbidopa/entacapona
PT100514A (pt) 3-aminoquinuclidinas substituidas e composicoes farmaceuticas que qs contem
BR9910066A (pt) Composição farmacêutica fluida que permite a liberação controlada de pelo menos uma substância ativa, processo de fabricação de uma composição farmacêutica, e, utilização de uma composição
EA200301165A1 (ru) Лекарственное средство на основе оксикодона
BG104727A (en) Pharmaceutical composition of topiramate
BG101118A (en) Therapeutical compounds
MX16658A (es) Procedimiento para la preparacion de derivados delacido difosfonico producto obtenido y composicion farmaceutica para el tratamiento de desordenes en el metabolismo del calcio que lo incluye.
HUT70482A (en) Immunopotentiatory pharmaceutical compositions containing carbonylgroups
DE69912808D1 (de) Verwendung von Hymenialdisin und dessen Derivaten zur Herstellung therapeutischer Mittel
SE8704248D0 (sv) Medical use
TR200101633T2 (tr) Farmasötik bileşim
ATE298324T1 (de) Deuterierte 3-piperidinopropiophenone sowie diese verbindungen enthaltende arzneimittel
AR003121A1 (es) Antagonistas del receptor de adhesión, procedimiento para prepararlos, composiciones farmacéuticas que los contienen y su empleo para preparar medicamentos y combatir enfermedades
ES2153906T3 (es) Uso de incienso para el tratamiento de la enfermedad de alzheimer.
ES2136167T3 (es) Composiciones de idebenona para tratar la enfermedad de alzheimer.
KR890003390A (ko) 골다공증 및 관련된 장해의 치료방법
BR9915729A (pt) Amidas Èmega de n-arilsulfonil-aminoácido
DK0612246T3 (da) Farmaceutiske sammensætninger af galliumkomplekser med 3-hydroxy-4-pyroner
ES2177024T3 (es) Empleo de la fanquinoma para el tratamiento de la enfermedaad de alzheimer.
ATE13488T1 (de) Gallium-chlorid, ein neues antikrebsmittel.
BR0312778A (pt) Composição farmacêutica para prevenção ou tratamento de arteriosclerose ou doenças derivadas de arteriosclerose, e, usos de um antagonista de receptor de adp e de um inibidor de acat
BR0112690A (pt) Medicamento contendo cilansetron para o tratamento de pacientes ibs masculinos não-obstipativos
DK0642338T3 (da) Anvendelse af (E)-2-(p-fluorphenethyl)-3-fluorallylamin i behandlingen af Alzheimers sygdom